Does gut dysbiosis disrupt bile acid recycling and increase hepatic synthesis and inflammation?

The relationship between gut microbiota health and bile acid metabolism is a critical axis in human physiology. Research suggests that gut dysbiosis significantly alters the bile acid pool, with profound implications for hepatic function and systemic inflammation.

Microbial impact on bile acid transformation

Gut dysbiosis—often characterized by shifts in the abundance of Bacteroides, Clostridium, and Enterococcus—can significantly alter the chemical composition of the bile acid pool. While some dysbiotic states reduce deconjugation, others involve an expansion of bacteria with high bile salt hydrolase (BSH) activity.

• Deconjugation: BSH enzymes remove glycine or taurine from primary bile acids. An overgrowth of BSH-producing opportunistic pathogens can lead to excessive deconjugation.
• Transformation: Dysbiotic shifts also influence 7α-dehydroxylation, the process that converts primary bile acids (CA and CDCA) into secondary bile acids (DCA and LCA).

Disruption of enterohepatic recycling

In a healthy state, approximately 95% of bile acids are reclaimed in the terminal ileum, primarily via the active transport protein ASBT (Apical Sodium-dependent Bile acid Transporter).

• Efficiency Loss: ASBT has a high affinity for conjugated bile acids. When dysbiosis increases deconjugation, these bile acids must rely on less efficient passive diffusion for reabsorption.
• Increased Excretion: This shift in transport mechanisms increases fecal bile acid loss, effectively breaking the efficient "closed-loop" recycling system.

Hepatic consequences and inflammatory signaling

The disruption of recycling triggers a cascade of hepatic and inflammatory responses through the FXR-FGF19 signaling axis.

• Synthesis Demand: Reduced bile acid return to the ileum decreases the activation of the Farnesoid X Receptor (FXR). This lowers the production of Fibroblast Growth Factor 19 (FGF19), which normally suppresses the hepatic enzyme CYP7A1. Without this suppression, de novo bile acid synthesis from cholesterol increases significantly to compensate for losses.
• Inflammatory Pathways: A lack of FXR and TGR5 receptor activation removes key brakes on pro-inflammatory transcription factors like NF-κB. Furthermore, the accumulation of hydrophobic secondary bile acids can trigger oxidative stress and the NLRP3 inflammasome, contributing to hepatic and intestinal inflammation.

Bottom line

The claim is strongly supported by mechanistic science: gut dysbiosis disrupts the enterohepatic cycle by altering bile acid chemistry, which forces a compensatory increase in hepatic synthesis and removes the anti-inflammatory protections normally afforded by proper bile acid signaling.